|Daily Range||$33.13 - $34.37|
|52-Week Range||$16.71 - $45.00|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||341,600|
|Current FY EPS||-$2.60|
Prothena Corporation (PRTA) Description
Prothena Corporation plc - Ordinary Shares Website: http://www.prothena.com/
These three biotechs have promising drugs in their pipelines that address billion dollar drug markets.
Prothena Announces Presentation of Clinical Data From the Ongoing Phase 1/2 NEOD001 Study and Systemic Amyloidosis Patient Survey Results
Phase 1 trial results for Prothena Corporation's PRX-002 could indicate that this drug may help treat Parkinson's disease someday.